source
- FDA cuts required analytical tests for emergency-use diagnostic devices in new guidanceOn 9 November 2026 the U.S. Food and Drug Administration released final guidance aimed at simplifying validation of in-vitro diagnostic devices used in public-health emergencies. The document outli…
- ARPA-H teams meet FDA within two months of launching autonomous clinical AI programMultiple teams in ARPA-H's Advocate program, which focuses on autonomous clinical AI tools, have already held an initial informational meeting with the FDA. The meeting took place less than two mo…